using germ-free rodents, it was demonstrated that when the microbiota of conventionally raised animals was transplanted into germ-free rodents, the latter developed an increase in adiposity and insulin resistance 3
But a spokesperson for Novo Nordisk has this week told The Pharmacist that while it has increased production, this will take time to take effect, and that it therefore envisaged intermittent supply shortages over the next 18 months
This paradigm shift is already influencing drug development pipelines
Watkins R, Swancutt D, Alexander M, Moghadam S, Perry S, Dean S, et al
Elevate your healthits the best investment you can make
USA 115 , E4061E4070 (2018)